UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 155

Sortiert nach

Response to therapy with interferon alpha-2b and prednisolone in aggressive systemic mastocytosis: report of five cases and review of the literature

Leukemia research, 2004-03, Vol.28 (3), p.249-257

2004

Volltextzugriff (PDF)

Definitions, Criteria and Global Classification of Mast Cell Disorders with Special Reference to Mast Cell Activation Syndromes: A Consensus Proposal

International archives of allergy and immunology, 2012-02, Vol.157 (3), p.215-225

2012

Volltextzugriff (PDF)

Mast cells as a unique hematopoietic lineage and cell system: From Paul Ehrlich's visions to precision medicine concepts

Theranostics, 2020-01, Vol.10 (23), p.10743-10768

2020

Volltextzugriff (PDF)

Advances in the Classification and Treatment of Mastocytosis: Current Status and Outlook toward the Future

Cancer research (Chicago, Ill.), 2017-03, Vol.77 (6), p.1261-1270

2017

Volltextzugriff (PDF)

Refined diagnostic criteria and classification of mast cell leukemia (MCL) and myelomastocytic leukemia (MML): a consensus proposal

Annals of oncology, 2014-09, Vol.25 (9), p.1691-1700

2014

Volltextzugriff (PDF)

Immunohistochemical detection of vascular endothelial growth factor (VEGF) in the bone marrow in patients with myelodysplastic syndromes: correlation between VEGF expression and the FAB category

Leukemia & lymphoma, 2006-03, Vol.47 (3), p.451-460

2006

Volltextzugriff (PDF)

The KIT D816V allele burden predicts survival in patients with mastocytosis and correlates with the WHO type of the disease

Allergy (Copenhagen), 2014-06, Vol.69 (6), p.810-813

2014

Volltextzugriff (PDF)

Advanced systemic mastocytosis: from molecular and genetic progress to clinical practice

Haematologica (Roma), 2016-10, Vol.101 (10), p.1133

2016

Volltextzugriff (PDF)

On the way to targeted therapy of mast cell neoplasms: identification of molecular targets in neoplastic mast cells and evaluation of arising treatment concepts

European journal of clinical investigation, 2004-08, Vol.34 (s2), p.41-52

2004

Volltextzugriff (PDF)

Updated Diagnostic Criteria and Classification of Mast Cell Disorders: A Consensus Proposal

HemaSphere, 2021-11, Vol.5 (11), p.e646-n/a

2021

Volltextzugriff (PDF)

Hematopoietic stem-cell transplantation for advanced systemic mastocytosis

Journal of clinical oncology, 2014-10, Vol.32 (29), p.3264-3274

2014

Volltextzugriff (PDF)

Proposed diagnostic criteria and classification of basophilic leukemias and related disorders

Leukemia, 2017-04, Vol.31 (4), p.788-797

2017

Volltextzugriff (PDF)

Systemic mastocytosis associated with acute myeloid leukaemia: report of two cases and detection of the c‐kit mutation Asp‐816 to Val

British journal of haematology, 1998-12, Vol.103 (3), p.740-749

1998

Volltextzugriff (PDF)

COVID-19 Vaccination in Mastocytosis: Recommendations of the European Competence Network on Mastocytosis (ECNM) and American Initiative in Mast Cell Diseases (AIM)

The journal of allergy and clinical immunology in practice (Cambridge, MA), 2021-06, Vol.9 (6), p.2139-2144

2021

Volltextzugriff (PDF)

BCR/ABL induces expression of vascular endothelial growth factor and its transcriptional activator, hypoxia inducible factor-1α, through a pathway involving phosphoinositide 3-kinase and the mammalian target of rapamycin

Blood, 2002-11, Vol.100 (10), p.3767-3775

2002

Volltextzugriff (PDF)

Recombinant Carp Parvalbumin, the Major Cross-Reactive Fish Allergen: A Tool for Diagnosis and Therapy of Fish Allergy

The Journal of immunology (1950), 2002-05, Vol.168 (9), p.4576-4584

2002

Volltextzugriff (PDF)

Allergen-specific immunotherapy with a monophosphoryl lipid A-adjuvanted vaccine: reduced seasonally boosted immunoglobulin E production and inhibition of basophil histamine release by therapy-induced blocking antibodies

Clinical and experimental allergy, 2003-09, Vol.33 (9), p.1198-1208

2003

Volltextzugriff (PDF)

Systemic mastocytosis with associated clonal haematological non-mast cell lineage diseases: a histopathological challenge

Journal of clinical pathology, 2004-06, Vol.57 (6), p.604-608

2004

Volltextzugriff (PDF)

Refined Treatment Response Criteria for Indolent Systemic Mastocytosis Proposed by the ECNM-AIM Consortium

The journal of allergy and clinical immunology in practice (Cambridge, MA), 2022-08, Vol.10 (8), p.2015-2024

2022

Volltextzugriff (PDF)

Diagnosis and treatment of systemic mastocytosis: state of the art

British journal of haematology, 2003-09, Vol.122 (5), p.695-717

2003

Volltextzugriff (PDF)

Mastocytosis: Pathology, genetics, and current options for therapy

Leukemia & lymphoma, 2005, Vol.46 (1), p.35-48

2005

Volltextzugriff (PDF)

Induction of Differentiation of Human Mast Cells From Bone Marrow and Peripheral Blood Mononuclear Cells by Recombinant Human Stem Cell Factor/kit-Ligand in Long-Term Culture

Blood, 1992-11, Vol.80 (9), p.2237-2245

1992

Volltextzugriff (PDF)

Mast cell leukemia: clinical and molecular features and survival outcomes of patients in the ECNM Registry

Blood advances, 2023-05, Vol.7 (9), p.1713-1724

2023

Volltextzugriff (PDF)

Detection of molecular targets on the surface of CD34+ CD38− stem cells in various myeloid malignancies

Leukemia & lymphoma, 2006-02, Vol.47 (2), p.207-222

2006

Volltextzugriff (PDF)

Identification of heme oxygenase-1 as a novel BCR/ABL-dependent survival factor in chronic myeloid leukemia

Cancer research (Chicago, Ill.), 2004-05, Vol.64 (9), p.3148-3154

2004

Volltextzugriff (PDF)

1 – 25 von 155

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(155)
Mit Volltextzugriff
(140)

Publikationsform

Artikel
(155)

Sprache

Englisch
(155)
Japanisch
(42)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(151)
Science & Technology
(151)
Humans
(141)
Biological And Medical Sciences
(67)
Immunology
(60)
Hematology
(57)
Medical Sciences
(57)
Female
(46)
Male
(46)
Middle Aged
(44)
Adult
(41)
Allergy
(40)
Allergens - Immunology
(34)
Mast Cells
(33)
Oncology
(33)
Aged
(32)
Mastocytosis
(30)
Hematologic And Hematopoietic Diseases
(29)
Histamine Release
(26)
Immunoglobulin E - Immunology
(24)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Response to therapy with interferon alpha-2b and prednisolone in aggressive systemic mastocytosis: report of five cases and review of the literature

Definitions, Criteria and Global Classification of Mast Cell Disorders with Special Reference to Mast Cell Activation Syndromes: A Consensus Proposal

Mast cells as a unique hematopoietic lineage and cell system: From Paul Ehrlich's visions to precision medicine concepts

Advances in the Classification and Treatment of Mastocytosis: Current Status and Outlook toward the Future

Refined diagnostic criteria and classification of mast cell leukemia (MCL) and myelomastocytic leukemia (MML): a consensus proposal

Immunohistochemical detection of vascular endothelial growth factor (VEGF) in the bone marrow in patients with myelodysplastic syndromes: correlation between VEGF expression and the FAB category

The KIT D816V allele burden predicts survival in patients with mastocytosis and correlates with the WHO type of the disease

Advanced systemic mastocytosis: from molecular and genetic progress to clinical practice

On the way to targeted therapy of mast cell neoplasms: identification of molecular targets in neoplastic mast cells and evaluation of arising treatment concepts

Updated Diagnostic Criteria and Classification of Mast Cell Disorders: A Consensus Proposal

Hematopoietic stem-cell transplantation for advanced systemic mastocytosis

Proposed diagnostic criteria and classification of basophilic leukemias and related disorders

Systemic mastocytosis associated with acute myeloid leukaemia: report of two cases and detection of the c‐kit mutation Asp‐816 to Val

COVID-19 Vaccination in Mastocytosis: Recommendations of the European Competence Network on Mastocytosis (ECNM) and American Initiative in Mast Cell Diseases (AIM)

BCR/ABL induces expression of vascular endothelial growth factor and its transcriptional activator, hypoxia inducible factor-1α, through a pathway involving phosphoinositide 3-kinase and the mammalian target of rapamycin

Recombinant Carp Parvalbumin, the Major Cross-Reactive Fish Allergen: A Tool for Diagnosis and Therapy of Fish Allergy

Allergen-specific immunotherapy with a monophosphoryl lipid A-adjuvanted vaccine: reduced seasonally boosted immunoglobulin E production and inhibition of basophil histamine release by therapy-induced blocking antibodies

Systemic mastocytosis with associated clonal haematological non-mast cell lineage diseases: a histopathological challenge

Refined Treatment Response Criteria for Indolent Systemic Mastocytosis Proposed by the ECNM-AIM Consortium

Diagnosis and treatment of systemic mastocytosis: state of the art

Mastocytosis: Pathology, genetics, and current options for therapy

Induction of Differentiation of Human Mast Cells From Bone Marrow and Peripheral Blood Mononuclear Cells by Recombinant Human Stem Cell Factor/kit-Ligand in Long-Term Culture

Mast cell leukemia: clinical and molecular features and survival outcomes of patients in the ECNM Registry

Detection of molecular targets on the surface of CD34+ CD38− stem cells in various myeloid malignancies

Identification of heme oxygenase-1 as a novel BCR/ABL-dependent survival factor in chronic myeloid leukemia

Suchergebnisse filtern